Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?
Open Access
- 1 December 2022
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology Communications
- Vol. 2, 1-5
- https://doi.org/10.1016/j.clicom.2021.12.002
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Guillain-Barré Syndrome and VariantsNeurologic Clinics, 2013
- Clinical Variants of Guillain-Barré Syndrome in ChildrenPediatric Neurology, 2012
- Acute motor-sensory axonal Guillain–Barré syndrome with unilateral facial nerve paralysis after rotavirus gastroenteritis in a 2-year-old boyJournal of Infection and Chemotherapy, 2012
- Immunity to Campylobacter: its role in risk assessment and epidemiologyCritical Reviews in Microbiology, 2009
- GUILLAIN-BARRÉ SYNDROME COMPLICATING A CHIKUNGUNYA VIRUS INFECTIONNeurology, 2007
- Guillain-Barré Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research DatabasePLOS ONE, 2007
- Guillain-Barré syndromeThe Lancet, 2005
- Guillain-Barré Syndrome Following Influenza VaccinationJAMA, 2004
- Infectious causes of acute flaccid paralysisCurrent Opinion in Infectious Diseases, 2003
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992